Privia Health Group Inc. Reports Strong Q3 Results for 2024
Privia Health Group Inc. (NASDAQ: PRVA), a pioneering technology-driven healthcare company, has released its financial results for the third quarter of 2024, showcasing a year of growth and strategic expansion. With an emphasis on enhancing physician practices through its innovative Privia Platform, the company is well-positioned within the evolving landscape of value-based healthcare.
1. Financial Performance Overview
Privia Health's financial results for the third quarter and the first nine months of 2024 highlight a robust trajectory in both revenue and profitability. The company's revenue reached $437.9 million for the three months ending September 30, 2024, compared to $417.3 million in the same period of 2023, marking a notable increase of 4.0%. For the nine months ended September 30, 2024, revenue increased to $1.28 billion from $1.22 billion year-over-year.
Key Financial Highlights
- Gross Profit: Increased to $99.9 million for Q3 2024 from $90.6 million in Q3 2023.
- Operating Income: Rose slightly to $5.8 million in Q3 2024 compared to $5.5 million in Q3 2023.
- Net Income: Decreased to $3.5 million in Q3 2024 from $5.6 million in Q3 2023, primarily due to regulatory challenges impacting the company’s capitated revenue.
| Nov 2023 | Nov 2024 | |
|---|---|---|
Net Income | 38.01M | 12.82M |
Net Income to Non-controlling Interest | -2.46M | 1.17M |
Profit | 35.55M | 14.00M |
Net Income Continuing | 35.67M | 13.92M |
Income Tax Expense | -7.51M | 10.19M |
Pretax Income | 28.15M | 24.11M |
Non-operating Income | 6.67M | 10.96M |
Operating Income | 21.47M | 13.15M |
Revenue | 1.58B | 1.71B |
Costs and Expenses | 1.55B | 1.70B |
Operating Expenses | 1.55B | 1.70B |
Depreciation, Depletion & Amortization | 5.89M | 7.20M |
Selling, General & Administrative | 131.7M | 147.5M |
Other Operating Expenses | 1.42B | 1.54B |
2. Growth Metrics and Market Expansion
Privia Health has made significant strides in expanding its market presence. The number of implemented providers increased by 13.1%, while attributed lives surged by 14.0% as of September 30, 2024. These increases were driven by organic growth and successful entrances into new markets, including partnerships in Connecticut, Ohio, Washington, and South Carolina, with a recent announcement of a partnership in Indiana.
Performance Metrics
- Practice Collections: Grew by 2.3% in Q3 2024 and 4.5% for the nine-month period.
- Care Margin: Improved by 10.2% for Q3 2024, reflecting the company’s effective cost management and operational efficiencies.
- Platform Contribution: Increased by 11.2% in Q3 2024 compared to the previous year, showcasing the platform's growing value proposition.
3. Balance Sheet Strength
Privia Health's balance sheet reflects a solid financial foundation with total assets of $1.14 billion as of September 30, 2024, marking a substantial increase from $992.3 million in 2023. Current assets rose to $853.7 million, primarily driven by an increase in cash and receivables.
| Nov 2023 | Nov 2024 | |
|---|---|---|
Total Assets | 992.3M | 1.14B |
Total Current Assets | 697.6M | 853.7M |
Cash and Equivalents | 330.3M | 421.9M |
Accounts Receivable | 350.1M | 408.9M |
Prepaid Expenses | 17.16M | 22.79M |
Total Non-current Assets | 294.6M | 291.8M |
Intangible Assets | 242.8M | 242.5M |
Non-current Deferred Tax Assets | 35.18M | 27.56M |
Net PP&E | 2.59M | 1.45M |
Lease Assets | 7.10M | 5.28M |
Other Non-current Assets | 6.92M | 14.92M |
Total Liabilities and Equity | 992.3M | 1.14B |
Total Liabilities | 401.2M | 483.3M |
Total Current Liabilities | 394.1M | 479.4M |
Accounts Payable and Accrued Liabilities | 54.32M | 65.64M |
Current Debt | 3.22M | 2.58M |
Other Current Liabilities | 336.6M | 411.2M |
Total Non-current Liabilities | 7.08M | 3.91M |
Other Non-current Liabilities | 7.08M | 3.91M |
Total Equity and Non-controlling Interests | 591.0M | 662.1M |
Total Equity | 544.6M | 614.8M |
Non-controlling Interests | 46.37M | 47.29M |
Liabilities and Equity
Total liabilities stood at $483.3 million, with a significant portion attributed to current liabilities. The company’s equity increased to $662.1 million, highlighting its capacity to absorb losses and sustain growth amid challenges.
4. Cash Flow Insights
Privia Health reported a net change in cash of $34.64 million for Q3 2024, a significant improvement from $12.44 million in Q3 2023. This increase is indicative of strong operating cash flows, which totaled $33.15 million during the quarter.
| Nov 2023 | Nov 2024 | |
|---|---|---|
Net Change in Cash | 13.49M | 91.60M |
Net Cash from Operating Activities | 45.83M | 98.58M |
Operating Profit | 35.55M | 14.00M |
Adjustment to Operating Profit | 10.28M | 84.58M |
Net Cash from Investing Activities | -37.96M | -10.73M |
Business & Interest in Affiliates | 37.85M | 5.70M |
Productive Assets | 105K | 23K |
Other Investing Activities | 0 | -5.00M |
Net Cash from Financing Activities | 5.62M | 3.75M |
Equity Issuance/Repurchase | 10.74M | 2.01M |
Other Financing Activities | -5.12M | 1.74M |
5. Challenges and Strategic Initiatives
Despite the positive financial outcomes, Privia Health has faced regulatory and utilization headwinds within the Medicare Advantage space, impacting its capitated revenue. The company has actively renegotiated certain capitation agreements to secure more favorable terms, which are anticipated to yield positive contributions moving forward.
Additionally, Privia has committed to ongoing investments in growth, particularly in its technology platform and operational capabilities. The launch of Privia Care Partners aims to provide a flexible affiliation model for physicians, further enhancing the company’s collaborative network.
6. Conclusion
Privia Health Group Inc. continues to demonstrate resilience and strategic foresight in a competitive healthcare environment. The Q3 2024 financial results underscore the company's commitment to improving healthcare delivery through innovation and partnerships. As it navigates challenges in the regulatory landscape, Privia remains focused on long-term growth and enhancing value for its stakeholders. With its sights set on expanding into new markets and optimizing its operational efficiencies, Privia Health is poised for a promising future in the healthcare sector.
